Ginsenoside Compound K Protects against Obesity through Pharmacological Targeting of Glucocorticoid Receptor to Activate Lipophagy and Lipid Metabolism

INIS

• potassium compounds 100%
• receptors 75%
• glucocorticoids 75%
• obesity 25%
• proteins 25%
• lipids 25%
• lipase 25%
• mice 16%
• metabolism 16%
• fatty acids 16%
• weight 16%
• data 8%
• drugs 8%
• molecules 8%
• synthesis 8%
• energy 8%
• rna 8%
• homeostasis 8%
• fats 8%
• investigations 8%
• glucose 8%
• insulin 8%
• oxidation 8%
• tolerance 8%
• promoters 8%
• chromatin 8%
• blood 8%
• interference 8%
• streams 8%
• food 8%
• steroids 8%

Biochemistry, Genetics and Molecular Biology

• Glucocorticoid Receptor 75%
• Autophagy 25%
• Lipase 25%
• Electric Potential 16%
• Proteomics 16%
• Lipid Metabolism 16%
• Protein 16%
• Weight 16%
• Ginsenoside 16%
• Agonist 8%
• Steroid 8%
• Promoter Region 8%
• Binding Site 8%
• Chromatin Immunoprecipitation 8%
• Small Molecule 8%
• RNA Interference 8%
• Receptor Agonists 8%
• Beta Oxidation 8%
• Mouse Mutant 8%
• Insulin 8%
• Blood Lipids 8%
• Receptor Binding 8%
• Energy 8%
• Glucose Homeostasis 8%
• Mouse 8%
• Independent Pathway 8%
• Fatty Acid Synthesis 8%
• Protein Synthesis 8%
• ULK1 8%
• Experiment 8%
• Fat 8%
• Small Interfering RNA 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Glucocorticoid Receptor 75%
• Lipid 25%
• Obesity 25%
• Pancreatic Lipase 25%
• Protein 16%
• Fatty Acid 16%
• Binding Site 8%
• RNA 8%
• Insulin 8%
• Small Interfering RNA 8%
• Steroids 8%
• Glucose 8%
• Receptor Agonist 8%
• Regulator Protein 8%
• Mouse Mutant 8%
• Agonist 8%
• Drug 8%
• Tetrahydrolipstatin 8%
• Mouse 8%
• Fat 8%
• Chromatin Immunoprecipitation 8%